China
Retrospective cohort study
Medical records
208
aimed to clarify the high-risk factors with multivariate analysis and establish a prediction of disease progression
Overall, 208 consecutive confirmed patients with COVID-19 presented to two centers were enrolled from January 20 through February 22, 2020, the follow-up period ended in March 18, 2020.
Total
25 Day
COVID-19 (severe/critical)
40
COVID-19 (progression): All the consecutive patients with COVID-19 admitted to Fuyang second people??s hospital or the fifth medical center of Chinese PLA general hospital between January 20 and February 22, 2020, were enrolled and their clinical data were retrospectively collected.
Patient characteristics
Age
(age > 60 year)
<=60 years
>60 years
Hazard ratio
3.000 (1.400-6.000)
No
Yes
D-dimer, underlying comorbidity, older age, higher LDH and lower lymphocyte
Using the CALL score model, clinicians can improve the therapeutic effect and reduce the mortality of COVID-19 with more accurate and reasonable resolutions on medical resources.
Good